MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases

MucinB5 rs (35705950) Gene Polymorphism and Leucocytes Telomere Length in Relation to Interstitial Lung Diseases.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06498141

Enrollment

100

Registered

2024-07-12

Start date

2023-10-01

Completion date

2024-12-31

Last updated

2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucin B5 rs (35705950) Gene Polymorphism in Interstitial Lung Diseases

Brief summary

This is an observertional study aimed at Study the association between Mucin B5 rs (35705950) gene polymorphism and Leucocytes telomere length in relation to interstitial lung diseases.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

This study will include patients with interstitial lung diseases aged above 18 years old.

Exclusion criteria

* patients with emphysema or obstructive lung diseases. * patients with active cancer * End stage renal failure (GFR \< 30 ml/min) or on dialysis * Liver cell failure

Design outcomes

Primary

Measure	Time frame	Description
MucinB5 rs (35705950) gene polymorphism	6 Months	whether homogenetic or heterogenetic
Leucocytes telomere length	6 months	Measurement of the relative length of WBCs telomere in patints with interstitial pulmonary fibrosis

Countries

Egypt

Contacts

Primary ContactAmera Morad Foad, professor

ameramoradfoad@gmail.com+201006591449

Outcome results